BENGALURU | 25 August 2026: Israel-based Bioforum The Data Masters, a global biometric Contract Research Organization (CRO), has opened its new India Global Capability Centre (GCC) in Bengaluru, strengthening its global delivery network and expanding its ability to support complex clinical development programmes.

The Bengaluru centre brings together clinical data managers, statistical programmers, standards experts and technology specialists as part of Bioforum’s global delivery organisation. Integrated with the company’s operations across the United States, Europe, Colombia and South Africa, the India GCC strengthens its follow-the-sun delivery model, enabling continuous support for clean, compliant and submission-ready clinical data.

The development follows Bioforum’s decision in January 2026 to establish its India operations and GCC under the leadership of Dr. Santhosh Kumar, Senior Vice President, India & Global Capability Center. The company now expects the Bengaluru centre to grow significantly across clinical data management, statistical programming, clinical coding, validation and other core delivery capabilities.

More importantly, the expansion illustrates a wider shift in India’s life sciences capability landscape: specialist CROs are increasingly building domain-led global capabilities in India, with clinical data, statistics, technology and regulatory-quality execution becoming integrated rather than operating as separate support functions.

KEY HIGHLIGHTS

  • Specialist GCC: The Bengaluru centre brings together clinical data management, statistical programming, standards, technology and related clinical delivery capabilities.
  • Follow-the-Sun Delivery: The India GCC complements Bioforum’s operations across multiple geographies, strengthening its ability to provide continuous global delivery coverage.
  • Leadership in Place: The centre is led by Dr. Santhosh Kumar, SVP, India & GCC, who brings more than two decades of CRO and healthcare leadership experience.
  • FSP at Scale: The Bengaluru operation expands Bioforum’s ability to support Functional Service Provider (FSP) models, giving sponsors greater flexibility to build global clinical teams around evolving programme requirements.
  • Capability Expansion: Bioforum expects the centre to scale across clinical data management, statistical programming, clinical coding, validation and other core delivery capabilities.

Headquartered in Ness Ziona, Israel, Bioforum The Data Masters is a biometric Contract Research Organization (CRO). Originally founded in 1998 as a knowledge-sharing network for life science professionals, the enterprise evolved into a dedicated, data-focused CRO in 2008.

Operating independently of traditional clinical trial execution (like patient recruitment or site management), the privately held firm focuses exclusively on the data-centric phases of clinical research. Its core competencies encompass clinical data management, biostatistics, statistical programming, and medical writing. Functioning on a global scale, Bioforum provides Functional Service Provider (FSP) models and full-service biometric solutions to emerging biotech startups, medical device companies, and large pharmaceutical enterprises to accelerate the delivery of life-changing therapies to market.

Industry Insights

Proofpoint’s expansion highlights several broader shifts in India’s capability-centre ecosystem:

  1. Specialist GCCs Are Expanding the Definition of Global Capability: Bioforum’s centre demonstrates that GCC growth is no longer limited to technology, finance or enterprise operations. Highly specialised domains such as clinical data sciences, biostatistics and regulatory-quality data management are increasingly becoming part of India’s global capability portfolio.
  2. Scientific Expertise Is Becoming a GCC Differentiator: The value proposition is shifting from access to a large talent pool towards access to specialised talent with domain depth. For clinical research, that means statisticians, programmers, data managers, coding specialists and other professionals who understand both scientific requirements and regulatory expectations.
  3. FSP Is Creating More Flexible Global Talent Models: Bioforum’s emphasis on FSP reflects a broader movement towards modular global capability. Sponsors can augment internal teams with specialist expertise without having to build every capability themselves, making scalable specialist centres increasingly relevant.
  4. Follow-the-Sun Is Evolving into Follow-the-Expertise: The traditional rationale for follow-the-sun models was largely time-zone coverage. Bioforum’s model adds another dimension: specialised expertise can be distributed across geographies and handed across time zones without breaking continuity of delivery.
  5. Technology Is Becoming Embedded in Clinical Data Operations: Bioforum’s broader technology portfolio, including BioGRID’s analytics and AI capabilities, illustrates how clinical data operations are becoming increasingly technology-enabled. The future operating model is not simply people processing clinical data; it is domain experts working with platforms, analytics and automation to improve data quality, oversight and decision-making.

FROM CLINICAL DATA DELIVERY TO GLOBAL CAPABILITY

Bioforum’s Bengaluru expansion is significant because of what is being located in India, not simply how many people may eventually be hired. Bioforum is a specialist CRO focused on the data-intensive side of clinical research, with capabilities spanning data management, biostatistics, statistical programming, medical writing and biometrics project management. Its technology portfolio also includes solutions such as BioGRID, which brings clinical-trial data together for analytics, visualisation and decision-making.

The Bengaluru GCC therefore represents a capability model built around scientific and technical expertise, rather than generic process delivery.

The company says the centre will work alongside sponsors on global studies and regulatory submissions, with quality and scientific rigour embedded in delivery. That is particularly relevant to India’s evolving role in clinical research, where the opportunity is moving from executing discrete activities to owning increasingly integrated parts of the clinical data lifecycle.

THE FSP OPPORTUNITY

One of the most consequential aspects of the expansion is Bioforum’s emphasis on FSP delivery.

FSP models allow pharmaceutical and biotech companies to supplement their internal clinical teams with specialist external capabilities. For Bioforum, a larger India GCC creates greater flexibility to assemble teams across clinical data management, statistical programming, coding and related functions while maintaining common governance and quality standards.

This makes India not merely a location for additional capacity, but an increasingly important component of globally distributed specialist clinical teams.

Bioforum’s move adds another layer to India’s expanding life sciences capability ecosystem.

The country’s proposition has historically been strongest in areas such as pharmaceutical manufacturing, clinical research support and technology services. Increasingly, global organisations are bringing these capabilities closer together, combining life sciences domain expertise with data, analytics, technology and specialised clinical skills.

Bengaluru is particularly relevant to this evolution because its technology ecosystem complements the specialist talent required for increasingly data-intensive clinical development.

Bioforum’s decision also demonstrates that this opportunity is not restricted to large pharmaceutical companies. Specialist CROs and life sciences service providers are themselves becoming builders of global capability centres in India.

STRATEGIC OUTLOOK

Bioforum’s Bengaluru GCC marks an important step in the evolution of India’s life sciences capability landscape. The significance lies not simply in another global healthcare company establishing an Indian centre, but in the depth of capability being assembled: clinical data management, biostatistics, statistical programming, coding, validation and technology-enabled delivery.

For India, this reinforces a broader shift – from being a source of clinical operations capacity to becoming a location where specialist global capabilities can be built, integrated and delivered at scale. As clinical development becomes increasingly data-intensive and technology-enabled, centres combining scientific expertise with digital capability are likely to become an increasingly important part of the global life sciences operating model.

Bioforum’s Bengaluru GCC is a signal of where life sciences capability is heading: from outsourced clinical-data execution to integrated global capability. The competitive advantage is no longer simply scale—it is the ability to combine scientific depth, technology, regulatory rigour and global delivery within one operating model.

Curated by SSF Global

Tracking the shifts shaping GCCs, enterprise ecosystems, and the future of global business.

Share on      

SSF Global is a Global Community for Enterprise Function Leaders and serves as a research & advisory platform focused on Global Business Services (GBS), Global Capability Centres (GCCs), and the evolution of enterprise innovation in India and beyond. We track, publish, and partner in narratives that shape how capability centres transform into hubs of trust, intelligence, and sustainable growth. We also evaluate, assess and benchmark the GCCs for their performance, maturity and other parameters using our proprietary tools built from the knowledge gained from direct interaction with our members (GCCs & GBS).